Public health analysts for the state of Vermont recently crunched the numbers to find out if there's any truth to the myth.

GE HealthCare gets downgraded slightly to a hold from my prior buy rating last fall, agreeing with Seeking Alpha's quant ...

As part of a "secret shopper" study, New Mexico legislative analysts confirmed what many New Mexicans already knew all too well. The typical new patient has to make six or seven phone calls to book an ...

Bank of America maintains a Buy rating on Palantir stock and raises price target to $215. Here’s why the investment firm ...

The announcement from President Donald Trump about a possible link between the use of Tylenol during pregnancy and autism is ...

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

Analysts report $11 billion in spending even as the state serves 31,000 fewer residents and patients struggle with long waits ...

Bitcoin price rose for two consecutive days as it moved from a low of $108,650 to nearly $114,000. BTC has formed a ...

Omega Healthcare Investors (OHI) remains a Buy, offering a resilient and potentially growing 6.4% yield, solid AFFO growth, ...

Surging interest in artificial intelligence (AI) and cloud computing has pushed technology stocks sharply higher this year.

A US Bureau of Labor Statistics report forecasts a 3.1% job growth, adding 5.2 million jobs by 2034, despite automation and ...

Hims & Hers Health ( ($HIMS) ) has issued an announcement. Hims & Hers Health, Inc. has announced that it will disseminate information about its ...